Terns Pharmaceuticals's total assets for Q3 2025 were $301.65M, a decrease of -5.86% from the previous quarter. TERN total liabilities were $17.59M for the fiscal quarter, a 15.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.